ProCE Banner Activity

Near Future Directions in Treating CLL: Promising Agents and Combinations Under Investigation

Slideset Download

Download this slideset from a live symposium at ASH 2021 to review emerging investigational agents and combination therapies in CLL.

Released: December 09, 2021

Expiration: December 08, 2022

Share

Faculty

Shuo Ma

Shuo Ma, MD, PhD

Professor of Medicine
Division of Hematology/Oncology
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.

Genentech, a member of the Roche Group

Janssen Biotech Pharmacyclics Abbvie

Faculty Disclosure

Primary Author

Shuo Ma, MD, PhD

Professor of Medicine
Division of Hematology/Oncology
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Shuo Ma, MD, PhD: consultant/advisor/speaker: AbbVie, AstraZeneca, Bristol Myers Squibb, BeiGene, Invivyd, Janssen, Lilly Oncology.